ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,212.20
0.10%
S&P ASX All Technology
3,444.90
0.35%
Brent Oil
70.755
-0.27%
US Dollar vs AUD
1.44382
-0.49%
Bitcoin
65,450.00
0.41%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Durect Corp (DRRX)

  7. Durect Corp (DRRX) News

DRRX

Durect (DRRX)

Durect Corp
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DRRX
DateTimeSourceHeadlineSymbolCompany
26/09/202401:24Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:DRRXDurect Corp
25/09/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
25/09/202422:00PR Newswire (US)DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated HepatitisNASDAQ:DRRXDurect Corp
12/09/202402:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRRXDurect Corp
05/09/202406:30PR Newswire (US)DURECT Corporation to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:DRRXDurect Corp
26/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRRXDurect Corp
15/08/202407:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:DRRXDurect Corp
14/08/202406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
13/08/202406:15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:DRRXDurect Corp
13/08/202406:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DRRXDurect Corp
13/08/202406:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:DRRXDurect Corp
07/08/202403:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRRXDurect Corp
07/08/202403:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRRXDurect Corp
03/08/202406:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:DRRXDurect Corp
31/07/202406:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRRXDurect Corp
31/07/202406:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
22/05/202406:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
21/05/202422:00PR Newswire (US)DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
15/05/202406:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRRXDurect Corp
14/05/202406:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
14/05/202406:05PR Newswire (US)DURECT Corporation Reports First Quarter 2024 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
08/05/202406:30PR Newswire (US)DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
30/04/202421:00PR Newswire (US)DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
28/03/202407:01PR Newswire (US)DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:DRRXDurect Corp
21/03/202407:30PR Newswire (US)DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
05/03/202403:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
04/03/202423:00PR Newswire (US)DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and CanadaNASDAQ:DRRXDurect Corp
15/02/202408:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DRRXDurect Corp
08/02/202410:48PR Newswire (US)DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:DRRXDurect Corp
23/12/202308:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
 Showing the most relevant articles for your search:NASDAQ:DRRX

Your Recent History

COIN
AVAXUSD
Avalanche
FX
AUDCAD
AUD vs CAD
ASX
SUN
Suncorp
NASDAQ
TSLA
Tesla
ASX
WPL
Woodside Petroleum
NASDAQ
AAPL
Apple
PM
XAUUSD
Gold vs US Dollar
FX
EURAUD
Euro vs AUD
FX
GBPAUD
Sterling vs AUD
ASX
ORG
Origin Energy
ASX
CSL
CSL
ASX
QBE
QBE Insurance
FTSE
UKX
FTSE 100
NYSE
KO
Coca Cola
NYSE
MRK
Merck
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved